School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
BMC Geriatr. 2023 Mar 23;23(1):166. doi: 10.1186/s12877-023-03878-2.
Older inpatients, particularly those with frailty, have increased exposure to complex medication regimens. It is not known whether frailty and complexity of medication regimens influence attitudes toward deprescribing. This study aimed to investigate (1) older inpatients' attitudes toward deprescribing; (2) if frailty and complexity of medication regimen influence attitudes and willingness to deprescribe - a relationship that has not been investigated in previous studies.
In this cross-sectional study, older adults (≥ 65 years) recruited from general medicine and geriatric services in a New Zealand hospital completed the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire. Hospital frailty risk score (HFRS) was calculated using diagnostic codes and other relevant information present at the time of index hospital admission; higher scores indicate higher frailty risk. Medication regimen complexity was quantified using the medication regimen complexity index (MRCI); higher scores indicate greater complexity. Logistic regression analysis was used to identify predictors of attitudes and willingness to deprescribe.
A total of 222 patients were included in the study, the median age was 83 years and 63% were female. One in two patients reported feeling they were taking too many medications, and 1 in 5 considered their medications burdensome. Almost 3 in 4 (73%) wanted to be involved in decision-making about their medications, and 4 in 5 (84%) were willing to stop one or more of their medications if their prescriber said it was possible. Patients with higher MRCI had increased self-reported medication burden (adjusted odds ratio (AOR) 2.6, 95% CI 1.29, 5.29) and were more interested in being involved in decision-making about their medications (AOR 1.8, CI 0.99, 3.42) than those with lower MRCI. Patients with moderate HFRS had lower odds of willingness to deprescribe (AOR 0.45, CI 0.22,0.92) compared to the low-risk group. Female patients had a lower desire to be involved in decision-making. The oldest old age group( > 80 years) had lower self-reported medication burden and were less likely to want to try stopping their medications.
Most older inpatients wanted to be involved in decision-making about their medications and were willing to stop one or more medications if proposed by their prescriber. Medication complexity and frailty status influence patients' attitudes toward deprescribing and thus should be taken into consideration when making deprescribing decisions. Further research is needed to investigate the relationship between frailty and the complexity of medication regimens.
老年住院患者,尤其是体弱患者,接触复杂药物治疗方案的风险增加。目前尚不清楚体弱和药物治疗方案的复杂性是否会影响对药物减量的态度。本研究旨在调查:(1)老年住院患者对药物减量的态度;(2)如果体弱和药物治疗方案的复杂性会影响对药物减量的态度和意愿——这是之前的研究中尚未探讨过的关系。
在这项横断面研究中,从新西兰一家医院的普通内科和老年科招募了年龄在 65 岁及以上的老年人,他们完成了修订后的患者对药物减量的态度问卷(rPATD)。使用诊断代码和入院时其他相关信息计算医院衰弱风险评分(HFRS);得分越高表示衰弱风险越高。使用药物治疗方案复杂性指数(MRCI)量化药物治疗方案的复杂性;得分越高表示复杂性越大。使用逻辑回归分析确定态度和愿意药物减量的预测因素。
共有 222 名患者纳入研究,中位年龄为 83 岁,63%为女性。有 1/2 的患者表示他们正在服用过多的药物,有 1/5 的患者认为他们的药物有负担。近 4/5(73%)的患者希望参与自己药物治疗的决策,有 4/5(84%)的患者如果他们的医生说有可能,他们愿意停止服用一种或多种药物。MRCI 较高的患者报告的药物负担更大(调整后的优势比(AOR)2.6,95%CI 1.29,5.29),并且更有兴趣参与自己药物治疗的决策(AOR 1.8,CI 0.99,3.42),而 MRCI 较低的患者则没有(AOR 1.8,CI 0.99,3.42)。HFRS 为中度的患者与低危组相比,更不愿意进行药物减量(AOR 0.45,CI 0.22,0.92)。女性患者参与决策的意愿较低。年龄最大的老年组(>80 岁)的药物负担自评较低,并且不太愿意尝试停止服用药物。
大多数老年住院患者希望参与自己的药物治疗决策,如果医生建议,他们愿意停止服用一种或多种药物。药物复杂性和体弱状况会影响患者对药物减量的态度,因此在做出药物减量决策时应考虑这些因素。需要进一步研究以探讨衰弱与药物治疗方案复杂性之间的关系。